| 摘要 |
A treatment is disclosed for alleviation or prevention of abnormal blood flow to various organs such as the eye, brain, kidneys, heart, feet and othe r tissues of organs with fine vascular networks that can lead to neurodegene ration as is seen in wet age- related macular degeneration (AMD), epilepsy a nd diabetes, in which an effective amount of a blood flow regulatory drug is administered to a subject in need of it. Illustrative blood flow regulatory drugs include anticoagulants and vasodilators, and their mixtures. |
